1. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1996; 114:417–24.
2. Kim SY, Kim SJ, Yu YS. Early Laser Treatment of Rush-Type Retinopathy of Prematurity. J Korean Ophthalmol Soc. 2005; 46:448–55.
3. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969; 68:578–94.
Article
4. Canny CL, Oliver GL. Fluorescein angiographic findings in familial exudative vitreoretinopathy. Arch Ophthalmol. 1976; 94:1114–20.
Article
5. Watzke RC, Stevens TS, Carney RG Jr. Retinal vascular changes of incontinentia pigmenti. Arch Ophthalmol. 1976; 94:743–6.
Article
6. Francois J. Incontinentia pigmenti (Bloch-Sulzberger syndrome) and retinal changes. Br J Ophthalmol. 1984; 68:19–25.
Article
7. Tasman W, Augsburger JJ, Shields JA, et al. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1981; 79:211–26.
8. Benson WE. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc. 1995; 93:473–521.
9. Holmström G, Thorén K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand. 2000; 78:348–53.
Article
10. Yu YS, Park KC. Retinal Vascular Changes and Treatment of incontinentia Pigmenti Eyes. J Korean Ophthalmol Soc. 1998; 39:1823–30.
11. Shukla D, Singh J, Sudheer G, et al. Familial exudative vitreoretino- pathy (FEVR). Clinical profile and management. Indian J Opht- halmol. 2003; 51:323–8.
12. Ebert EM, Mukai S. Familial exudative vitreoretinopathy. Int Ophthalmol Clin. 1993; 33:237–47.
Article
13. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy. Results of surgical management. Ophthalmology. 1998; 105:1015–23.
Article